Cizzle Biotechnology Holdings Plc (LON:CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
3.530
+0.380 (12.06%)
Jun 16, 2026, 1:27 PM GMT
Market Cap13.39M +87.6%
Revenue (ttm)n/a
Net Income-691.00K
EPS-0.00
Shares Out 424.96M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,652,332
Open3.400
Previous Close3.150
Day's Range3.220 - 3.900
52-Week Range1.200 - 3.900
Beta0.02
Analystsn/a
Price Targetn/a
Earnings DateJun 26, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 5
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements